Improving Treatment of Guanidinoacetate Methyltransferase Deficiency: Reduction of Guanidinoacetic Acid in Body Fluids by Arginine Restriction and Ornithine Supplementation
- 31 December 2001
- journal article
- case report
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 74 (4), 413-419
- https://doi.org/10.1006/mgme.2001.3257
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- X-Linked Creatine-Transporter Gene (SLC6A8) Defect: A New Creatine-Deficiency SyndromeAmerican Journal of Human Genetics, 2001
- Irreversible brain creatine deficiency with elevated serum and urine creatine: A creatine transporter defect?Annals of Neurology, 2001
- Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization studyMolecular Brain Research, 2001
- Neuroprotective effects of creatine administration against NMDA and malonate toxicityBrain Research, 2000
- Creatine replacement therapy in guanidineoacetate methyltransferase deficiency, a novel inborn error of metabolismThe Lancet, 1996
- Creatine Deficiency in the Brain: A New, Treatable Inborn Error of MetabolismPediatric Research, 1994
- Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult miceJournal of the Neurological Sciences, 1992
- Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animalsMetabolism, 1992
- Guanidino compounds that are increased in hyperargininemia inhibit GABA and glycine responses on mouse neurons in cell cultureEpilepsy Research, 1991
- Effects of α-keto-δ-guanidinovaleric acid on inhibitory amino acid responses on mouse neurons in cell cultureBrain Research, 1988